MICHAL LOTEM, Université de Montréal

Research

Cancer Immune Cell Receptors Melanoma Mouse Models Nk Cells Signaling T Cells

Latest funding

SLAMF6 and 2B4: roles and modes of action in normal immunity and cancer immunotherapy
CIHR · 2016 · Principal investigator

All 1 grants and awards

SLAMF6 and 2B4: roles and modes of action in normal immunity and cancer immunotherapy

Principal investigatorCIHR2016Joint Canada-Israel Health Research Program

Principal investigators: Veillette, André; LOTEM, MICHAL

Keywords: Cancer; Immune Cell Receptors; Melanoma; Mouse Models; Nk Cells; Signaling; T Cells

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Cancer Dear Professor LOTEM, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on cancer connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]